Novavax | NVAX - Trade Debtors

Stock Price
10.11
Daily Change
0.88 9.53%
Monthly
18.38%
Yearly
69.21%
Q2 Forecast
7.87

Novavax reported $106.45M in Trade Debtors for its fiscal quarter ending in December of 2025.





Trade Debtors Change Date
Adma Biologics USD 158.43M 20.76M Dec/2025
Agenus USD 22.44M 1.14M Dec/2025
AstraZeneca USD 17.88B 1.17B Mar/2026
BioCryst Pharmaceuticals USD 106.82M 15.49M Dec/2025
Cassava Sciences USD 120K 697K Dec/2025
Geron USD 39.23M 1.57M Dec/2025
GlaxoSmithKline GBP 7.94B 178M Mar/2026
MannKind USD 28.14M 10.23M Mar/2026
Merck USD 11.78B 345M Dec/2025
Moderna USD 71M 113M Mar/2026
Novartis USD 12.29B 3.3B Dec/2025
Novavax USD 106.45M 72.27M Dec/2025
Pfizer USD 16.17B 332M Mar/2026
Sanofi EUR 482M 85M Mar/2026
Sarepta Therapeutics USD 547.91M 149.68M Mar/2026
TG Therapeutics USD 392.05M 86.42M Mar/2026